Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET® CC-96191
CD33/CD16a/NKG2D 免疫调节 TriNKET® CC-96191 抗白血病活性的临床前表征
期刊:Cancers
影响因子:
doi:10.3390/cancers16050877
Margaret C Lunn-Halbert, George S Laszlo, Sarah Erraiss, Mark T Orr, Heidi K Jessup, Heather J Thomas, Henry Chan, Mahan A Jahromi, Jonathan Lloyd, Ann F Cheung, Gregory P Chang, Tanmay Dichwalkar, Daniel Fallon, Asya Grinberg, Eduardo Rodríguez-Arbolí, Sheryl Y T Lim, Allie R Kehret, Jenny Huo, Fra
